Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians

Maria Rosaria Rizzo, Emilia Ragno, Michelangela Barbieri, Domenico De Lucia, Daniela Manzella, Maria Rosaria Tagliamonte, Donatella Colaizzo, Maurizio Margaglione, Giuseppe Paolisso

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Previous studies demonstrated a relationship between the degree of insulin resistance and plasma plasminogen activator inhibitor type-1 (PAI-1) levels. We aim at investigating the relationship between the degree of insulin resistance and plasma PAI-1 levels in aged subjects (n = 83) and in healthy centenarians (n = 42). In all subjects the degree of insulin resistance was assessed by HOMA method. Our data demonstrated that healthy centenarians have higher plasma PAI-1 levels (73.1 ± 13.9 vs 23.7 ± 14.7 ng/ml, P <0.001) and lower degree of insulin resistance (1.4 ± 0.5 vs 3.3 ± 1.3, P <0.001) than aged subjects. In aged subjects plasma PAI-1 levels correlated with the degree of insulin resistance (r = 0.61, P <0.001), fasting plasma triglycerides (r = 0.74, P <0.001) and age (r = 0.33, P <0.001). All such associations were lost in centenarians. Plasma PAI-1 Ag levels were also similar in aged subjects and centenarians even after categorization for PAI gene polymorphism. In multivariate analysis, a model made by age, sex, body mass index, fasting plasma triglycerides, HOMA and PAI-1 gene explained 65 and 50% of plasma PAI-1 level variations in aged subjects and centenarians, respectively. Nevertheless, HOMA (P <0.001) was significantly and independently associated with plasma PAI-1 levels only in aged subjects. In conclusion, our data demonstrates that in healthy centenarians, plasma PAI-1 were not associated with the degree of insulin resistance as in aged subjects. Frequency of PAI-1 genotype does not provide an explanation for such differences between aged subjects and centenarians.

Original languageEnglish
Pages (from-to)385-390
Number of pages6
JournalAtherosclerosis
Volume160
Issue number2
DOIs
Publication statusPublished - 2002

Fingerprint

Plasminogen Activator Inhibitor 1
Insulin Resistance
Genes
Fasting
Triglycerides
Body Mass Index
Multivariate Analysis
Genotype

Keywords

  • Aged subjects
  • Centenarians
  • Insulin resistance
  • PAI-1 gene polymorphism
  • Plasma plasminogen activator inhibitor type-1 levels

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Rizzo, M. R., Ragno, E., Barbieri, M., De Lucia, D., Manzella, D., Tagliamonte, M. R., ... Paolisso, G. (2002). Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians. Atherosclerosis, 160(2), 385-390. https://doi.org/10.1016/S0021-9150(01)00575-5

Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians. / Rizzo, Maria Rosaria; Ragno, Emilia; Barbieri, Michelangela; De Lucia, Domenico; Manzella, Daniela; Tagliamonte, Maria Rosaria; Colaizzo, Donatella; Margaglione, Maurizio; Paolisso, Giuseppe.

In: Atherosclerosis, Vol. 160, No. 2, 2002, p. 385-390.

Research output: Contribution to journalArticle

Rizzo, MR, Ragno, E, Barbieri, M, De Lucia, D, Manzella, D, Tagliamonte, MR, Colaizzo, D, Margaglione, M & Paolisso, G 2002, 'Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians', Atherosclerosis, vol. 160, no. 2, pp. 385-390. https://doi.org/10.1016/S0021-9150(01)00575-5
Rizzo, Maria Rosaria ; Ragno, Emilia ; Barbieri, Michelangela ; De Lucia, Domenico ; Manzella, Daniela ; Tagliamonte, Maria Rosaria ; Colaizzo, Donatella ; Margaglione, Maurizio ; Paolisso, Giuseppe. / Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians. In: Atherosclerosis. 2002 ; Vol. 160, No. 2. pp. 385-390.
@article{1babdae5c2d64ef4a6d4758574493cd1,
title = "Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians",
abstract = "Previous studies demonstrated a relationship between the degree of insulin resistance and plasma plasminogen activator inhibitor type-1 (PAI-1) levels. We aim at investigating the relationship between the degree of insulin resistance and plasma PAI-1 levels in aged subjects (n = 83) and in healthy centenarians (n = 42). In all subjects the degree of insulin resistance was assessed by HOMA method. Our data demonstrated that healthy centenarians have higher plasma PAI-1 levels (73.1 ± 13.9 vs 23.7 ± 14.7 ng/ml, P <0.001) and lower degree of insulin resistance (1.4 ± 0.5 vs 3.3 ± 1.3, P <0.001) than aged subjects. In aged subjects plasma PAI-1 levels correlated with the degree of insulin resistance (r = 0.61, P <0.001), fasting plasma triglycerides (r = 0.74, P <0.001) and age (r = 0.33, P <0.001). All such associations were lost in centenarians. Plasma PAI-1 Ag levels were also similar in aged subjects and centenarians even after categorization for PAI gene polymorphism. In multivariate analysis, a model made by age, sex, body mass index, fasting plasma triglycerides, HOMA and PAI-1 gene explained 65 and 50{\%} of plasma PAI-1 level variations in aged subjects and centenarians, respectively. Nevertheless, HOMA (P <0.001) was significantly and independently associated with plasma PAI-1 levels only in aged subjects. In conclusion, our data demonstrates that in healthy centenarians, plasma PAI-1 were not associated with the degree of insulin resistance as in aged subjects. Frequency of PAI-1 genotype does not provide an explanation for such differences between aged subjects and centenarians.",
keywords = "Aged subjects, Centenarians, Insulin resistance, PAI-1 gene polymorphism, Plasma plasminogen activator inhibitor type-1 levels",
author = "Rizzo, {Maria Rosaria} and Emilia Ragno and Michelangela Barbieri and {De Lucia}, Domenico and Daniela Manzella and Tagliamonte, {Maria Rosaria} and Donatella Colaizzo and Maurizio Margaglione and Giuseppe Paolisso",
year = "2002",
doi = "10.1016/S0021-9150(01)00575-5",
language = "English",
volume = "160",
pages = "385--390",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians

AU - Rizzo, Maria Rosaria

AU - Ragno, Emilia

AU - Barbieri, Michelangela

AU - De Lucia, Domenico

AU - Manzella, Daniela

AU - Tagliamonte, Maria Rosaria

AU - Colaizzo, Donatella

AU - Margaglione, Maurizio

AU - Paolisso, Giuseppe

PY - 2002

Y1 - 2002

N2 - Previous studies demonstrated a relationship between the degree of insulin resistance and plasma plasminogen activator inhibitor type-1 (PAI-1) levels. We aim at investigating the relationship between the degree of insulin resistance and plasma PAI-1 levels in aged subjects (n = 83) and in healthy centenarians (n = 42). In all subjects the degree of insulin resistance was assessed by HOMA method. Our data demonstrated that healthy centenarians have higher plasma PAI-1 levels (73.1 ± 13.9 vs 23.7 ± 14.7 ng/ml, P <0.001) and lower degree of insulin resistance (1.4 ± 0.5 vs 3.3 ± 1.3, P <0.001) than aged subjects. In aged subjects plasma PAI-1 levels correlated with the degree of insulin resistance (r = 0.61, P <0.001), fasting plasma triglycerides (r = 0.74, P <0.001) and age (r = 0.33, P <0.001). All such associations were lost in centenarians. Plasma PAI-1 Ag levels were also similar in aged subjects and centenarians even after categorization for PAI gene polymorphism. In multivariate analysis, a model made by age, sex, body mass index, fasting plasma triglycerides, HOMA and PAI-1 gene explained 65 and 50% of plasma PAI-1 level variations in aged subjects and centenarians, respectively. Nevertheless, HOMA (P <0.001) was significantly and independently associated with plasma PAI-1 levels only in aged subjects. In conclusion, our data demonstrates that in healthy centenarians, plasma PAI-1 were not associated with the degree of insulin resistance as in aged subjects. Frequency of PAI-1 genotype does not provide an explanation for such differences between aged subjects and centenarians.

AB - Previous studies demonstrated a relationship between the degree of insulin resistance and plasma plasminogen activator inhibitor type-1 (PAI-1) levels. We aim at investigating the relationship between the degree of insulin resistance and plasma PAI-1 levels in aged subjects (n = 83) and in healthy centenarians (n = 42). In all subjects the degree of insulin resistance was assessed by HOMA method. Our data demonstrated that healthy centenarians have higher plasma PAI-1 levels (73.1 ± 13.9 vs 23.7 ± 14.7 ng/ml, P <0.001) and lower degree of insulin resistance (1.4 ± 0.5 vs 3.3 ± 1.3, P <0.001) than aged subjects. In aged subjects plasma PAI-1 levels correlated with the degree of insulin resistance (r = 0.61, P <0.001), fasting plasma triglycerides (r = 0.74, P <0.001) and age (r = 0.33, P <0.001). All such associations were lost in centenarians. Plasma PAI-1 Ag levels were also similar in aged subjects and centenarians even after categorization for PAI gene polymorphism. In multivariate analysis, a model made by age, sex, body mass index, fasting plasma triglycerides, HOMA and PAI-1 gene explained 65 and 50% of plasma PAI-1 level variations in aged subjects and centenarians, respectively. Nevertheless, HOMA (P <0.001) was significantly and independently associated with plasma PAI-1 levels only in aged subjects. In conclusion, our data demonstrates that in healthy centenarians, plasma PAI-1 were not associated with the degree of insulin resistance as in aged subjects. Frequency of PAI-1 genotype does not provide an explanation for such differences between aged subjects and centenarians.

KW - Aged subjects

KW - Centenarians

KW - Insulin resistance

KW - PAI-1 gene polymorphism

KW - Plasma plasminogen activator inhibitor type-1 levels

UR - http://www.scopus.com/inward/record.url?scp=0036178391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036178391&partnerID=8YFLogxK

U2 - 10.1016/S0021-9150(01)00575-5

DO - 10.1016/S0021-9150(01)00575-5

M3 - Article

VL - 160

SP - 385

EP - 390

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -